The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized, double-blind, phase 3 study of jaktinib versus hydroxyurea (HU) in patients (pts) with intermediate-2 or high-risk myelofibrosis (MF).
 
Yi Zhang
No Relationships to Disclose
 
Hu Zhou
No Relationships to Disclose
 
Junling Zhuang
No Relationships to Disclose
 
Aili He
No Relationships to Disclose
 
Yarong Li
No Relationships to Disclose
 
Linhua Yang
No Relationships to Disclose
 
Xin Du
No Relationships to Disclose
 
Sujun Gao
No Relationships to Disclose
 
Guangsheng He
No Relationships to Disclose
 
Mei Hong
No Relationships to Disclose
 
Qian Jiang
No Relationships to Disclose
 
Zhongxing Jiang
No Relationships to Disclose
 
Kai Sun
No Relationships to Disclose
 
Lingling Yue
No Relationships to Disclose
 
Cuiping Zheng
No Relationships to Disclose
 
Zeping Zhou
No Relationships to Disclose
 
Zhi-Jian Xiao
No Relationships to Disclose
 
Jie Jin
No Relationships to Disclose